جامعة بلاد الرافدين - Bilad Alrafidain University - م.م اسيل جليل ابراهيم خلف

القسم	المرحلة	الفصل	رمز المقرر	الوحدات	توصيف	المقرر
طب الاسنان	المرحلة الرابعة	سنوي		5		امراض ماحول الاسنان Periodontics
طب الاسنان	المرحلة الخامسة	سنوي		5		امراض ماحول الاسنان Periodontics

المحاضرات الالكترونية

المحاضرات الالكترونية - 50

العام	المقرر	القسم	المرحلة	المحاضرة
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	TRAUMA FROM OCCLUSI
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	toll-like-receptors-in-periodontology
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Sonic and ultrasonic instrumentation and irrigation
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Smoking and Periodontal diseases
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Radiographic aids in periodontology
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	PERIODONTICS WITH OTHER ASPECT OF DENTISTRY
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Periodontal Surgery
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Periodontal regeneration
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Perio plastic Surgery
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	peri-implant anatomy
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	peri implant mucosa
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	PATHOGENESIS OF PERIODONTAL DISEASE
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	medically compromised patient2
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	medically compromised patient
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	local-drug-delivery
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	lasers-and-its-application-in-periodontics
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	laser
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	implant
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	immunity part 2( adaptive)
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	immunity part 1( innate)
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	HOST-PARASITE INTERACTIONS
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	healing
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	HALITOSIS
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	GCF
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Furcation involvement
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	EXAMINATION AND DIAGNOSIS OF PATIENT WITH PERIODONTAL DISEASE
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	EPIDEMIOLOGY
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Dentine Hypersensitivity
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Cementum
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	bone-loss-and-patterns-of-bone-destruction-55680561
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	Bone loss and patterns of bone destruction
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الخامسة	advanced periodontal diagnostic tech
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Phase I Therapy
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Treatment planning for patients With Periodontal Diseases
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	pocket
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Phase II Therapy surgical Therapy
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Phase I Therapy
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Periodontal ligament
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Periodontal instruments
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Periodontal indices
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Mucogingival surgery
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Gingival and periodontal pocket
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	EXAMINATION AND DIAGNOSIS OF PATIENT WITH PERIODONTAL DISEASE
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Etiology and Risk factors for periodontal diseases
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	dental stain
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	DENTAL PLAQUE BIOFILM
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	CLASSIFICATION OF PERIODONTAL DISEASE
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	CLASSIFICATION OF PERIODONTAL DISEASE
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	Anatomy of Periodontium
2024-2025	امراض ماحول الاسنان Periodontics	طب الاسنان	المرحلة الرابعة	alveolar process

البحوث

	2017	: Research Journal of Pharmaceutical, Biological and Chemical Sciences
Osteoporosis and periodontal disease stand for a major health problem principally in aged women with complex as well as recognized bidirectional association. Postmenopausal osteoporosis also known as type I osteoporosis typifies a common illness in womanly patients by the beginning of menopause, owing to estrogen reduction after menopause. Alendronate is a first line drug for treatment of postmenopausal osteoporosis and it is a powerful inhibitor of osteoclast action that diminish bone resorption moreover, it was suggested of having osteo stimulative property in vivo and in vitro as revealed through increase in bone matrix formation. Thus medical management of postmenopausal osteoporosis women with alendronate may well have valuable outcome on periodontal health condition. 1.To estimate and compare the periodontal health status of the study and control groups. 2. To assess the effect of alendronate treatment on clinical periodontal parameters (plaque index(PLI),gingival index(GI),bleeding on probing(BOP),probing pocket depth(PPD),and clinical attachment level(CAL) in postmenopausal women with osteoporosis.3.To correlate between Alendronate intake duration and clinical periodontal parameters. 90 participants, females only were conscripted in this study with age ranged from (55-65) years old, were divided into three groups, (30 subjects each):first control group systemically healthy with healthy periodontium, second group postmenopausal women with osteoporosis under alendronate treatment for (3-6)months(Alendronate group) ,third group postmenopausal women with osteoporosis only without alendronate treatment(Osteoporosis group), the last two groups were sub divided in to two sub group each one consist of 15 gingivitis and 15 periodontitis . Periodontal health status was determined by clinical periodontal examination of plaque index (PLI), gingival index (GI), bleeding on probing (BOP), probing pocket depth (PPD) and clinical attachment level (CAL). Postmenopausal women with osteoporosis demonstrated the highest median values of all clinical periodontal parameters followed by Alendronate group, then the control group with healthy periodontium and systemically healthy ( except for plaque index with higher value in Alendronate group). total correlation between drug intake duration and clinical periodontal parameters were weak negative non significant with ( BOP, PPD,CAL) except for( PLI , GI) there were strong positive highly significant and weak positive highly significant correlation respectively between them. Patients with osteoporosis had greater periodontal tissue destruction comparing with patients with alendronate treatment with less periodontal tissue destruction. Additionally alendronate treatment may have beneficial outcome on periodontal health status in postmenopausal women with osteoporosis and periodontal disease

	2018	Journal of Baghdad College of Dentistry
Background: All diseases concerning bone destruction such as osteoporosis and periodontal diseases share common pattern in which the osteoclast cells are absolutely responsible for bone resorption that occurred when osteoclast activity exceeds osteoblast activity. Osteoprotegrin (OPG) considered as novel soluble decoy receptor known as “bone protector” since it prevents extreme bone resorption through inhibition of differentiation and activity of osteoclast by competing for binding site. It binds to receptor activator of nuclear factor kappa-B ligand (RANKL) and prevent its interaction with receptor activator of nuclear factor kappa-B (RANK), thus inhibits osteoclast formation. TNF-α is a pro-inflammatory cytokines having a broad range of important roles in regulation of immune system and bone resorption through the stimulation of osteoclastogenesis. Alendronate (ALN) diminishes the expression of osteoclast activating factors and cytokines such as RANKL and enhances the production of decoy receptor osteoprotegerin in osteoblast cells. Moreover, it decreases the production of proinflammatory cytokines such as TNF-α by macrophage, stimulates apoptosis of monocyte-macrophage cell lines derivative and reduces inflammatory response. Aims of the Study: 1. To assess the effect of alendronate treatment on salivary levels of osteoprotegrin and TNF-α in postmenopausal women with osteoporosis and periodontal disease 2. To find any possible correlation between salivary levels of osteoprotegrin and TNF-α in control and study groups. Materials and Methods: Total sample of 90 female subjects (55-65 years) were divided into 3 groups, (30 subjects in each group): first control group involved systemically healthy subjects with healthy periodontium, second group involved postmenopausal women with osteoporosis under alendronate treatment for(3-6)months (alendronate group), third group involved postmenopausal women with osteoporosis without alendronate treatment(osteoporosis group). The last two groups were sub- divided in- to two sub –groups (15 subjects in each sub-group) of gingivitis and periodontitis subjects respectively. Salivary samples were collected from all subjects and salivary levels of osteoprotegrin and TNF- α were determined by enzyme –linked immune sorbent assay (ELISA). Results: Highest median value of salivary (OPG) was found in alendronate group followed by control group while the lowest value was found in osteoporosis group. Highest median value of TNF- α was found in osteoporosis group followed by control group and alendronate group respectively with highly significant differences between them. Spearman correlation between salivary levels of TNF-α and OPG showed non- significant correlation at all subgroups. Conclusion: Subjects with osteoporosis in this study had greater levels of TNF-α and decrease in the level of OPG comparing with patients under alendronate treatment. Alendronate treatment for women with osteoporosis and periodontal disease may have beneficial outcome.

	2023	Dentistry 3000
BACKGROUND: One hundred and twenty specimens were collected from pa,ents with Peri-implan,,s in the period from August 2022 un,l September 2022 from Baqub specialized dental center, in the province of Diyala. The goal of this work was to es,mate the frequency of Staphylococcus aureus and their ability to produce biofilms associated with Peri-implan,,s. Also, we aimed to assess the an,-biofilm property of Ciprofloxacin and Amoxicillin/clavulanic acid on Staphylococcus aureus. The result showed growth of Staphylococcus aureus in twenty isolates (16.6%), and 95% of the Staphylococcus aureus isolates had the ability to produce biofilms. The results indicate that the minimum inhibitory concentra,on (MIC) of Ciprofloxacin for Staphylococcus aureus was 32 to 512 μg/ml with the sub-MIC 16 to 256 μg/ml. The MIC for Amoxicillin/clavulanic was 8 to 512 μg/ml, and the sub-MIC 4 to 256) μg/ml. Ciprofloxacin and Amoxicillin/clavulanic acid had the ability to decrease biofilm forma,on and Amoxicillin/clavulanic acid was more effec,ve than Ciprofloxacin.

	2023	The Egyptian Journal of Hospital Medicine
Background: Application and development of oral health education (OHE) program is critical to recognize and to improve the risk of oral and dental health factors among adolescents. Aim: The purpose of the study was to evaluate the developments in the adolescents' oral health behavior and skills, in comparison with the pupils' situation before the teachers' training. Materials and Methods: Seven schools in the city of Diyala-Baquba participated in a randomized controlled experiment for this research. Eighty males and females aged 12 with good general health participated in this study over the course of 16weeks to evaluate the effects of a school-based OHE program on their oral hygiene, gum health, and halitosis. From the selected schools, one subjected to the intervention of OHE program and one of them was a control. A questionnaire was used to measure both general and oral health. In order to better prepare the teachers, a course lasting three days planned. To evaluate levels of oral hygiene, we used plaque indices, gingival indices, and halitosis scores to evaluate their breath. Results: Results showed that intervention school showed statistically significant improvements in student oral health indicators such plaque, gingivitis, and halitosis scores. Comparing teacher-led group to the controls and the baseline assessment, the former was found significantly lower scores for the plaque index, gingival index, and halitosis. There were significant differences discovered statistically (P< 0.01). Conclusions: School's children in the teacher-led OHE group showed significant improvements in their oral health, hygiene, gingival health, and oral malodor.

نشاطات التدريسي

البحوث المنشورة

المؤلفات

المقررات المكلف بها

المحاضرات

مشاريع التخرج

المقالات داخل المجلة

المقررات المكلف بها

المحاضرات الالكترونية

البحوث

Assessment of the effects of Alendronate treatment on clinical periodontal parameters in postmenopausal women with osteoporosis

Effect of Alendronate Treatment on Salivary Levels of Osteoprotegrin and TNF-α in Postmenopausal Woman with Osteoporosis and Periodontal Diseases

formation associated with Peri-implantitis Effects of antibiotics on Staphylococcus aureus biofilm

Oral Health Education (OHE) Program on Adolescents before and after Teacher's Training in Diyala City: A Comparative Clinical Study